MOL-6924
MOL-6924 cocaine hydrochloride, 3.5 mg/kg, was infused over a period of 10 s (total volume, 5 ml/kg).
Blood pressure was recorded continuously during this infusion and for 10 min thereafter.
Blood and tissue collection
To assess expression levels of virally transduced enzyme, blood samples were drawn from the tail vein, collected in heparinized tubes, and centrifuged at once to obtain plasma, which was stored at -80°C. The rats were then perfused through the aorta with 250-350 ml of 0.9% NaCl, and representative tissues were frozen at -80°C for later enzyme assay (completed within 24 h). To determine the fate of 3 H-cocaine after i.v. injection, miniature blood samples (100-200 µl) were drawn repeatedly from the femoral vein (less than 400 µl in all during the 10 min when blood pressure was monitored). Blood samples were collected in heparinized tubes containing BChE inhibitors (echothiophate and iso-OMPA, 10 -5 M final concentration, and NaF diluted 40-fold from a saturated solution). The same BChE inhibitors were added to the saline perfusion medium before collecting tissues for 3 H-cocaine determination.
Detection of mRNA for CocE
For RT-PCR analysis, mRNA was extracted from tissues using a FastTrak 2.0 kit (Invitrogen). Reverse transcription was carried out with 1 µg of mRNA using a Superscript II 1 st MOL-6924
antisense (5'-position 1349), TCA TCT ACC CAG TCT GTG. These primers amplified no DNA in mRNA preparations from naïve rats but with transduced rats they amplified a fragment spanning the two CocE mutations. As an assay control, a 508-bp fragment of rat cyclophilin was amplified with the following primers: sense (5'-position 49, Accession No. M19533), AAC CCC ACC GTG TTC TTC; and antisense (5'-position 557), ATG CCC GCA AGT CAA AGA.
RT-PCR reactions were performed in 50-µl volumes with the Hotstart Taq Master Mix (Qiagen) using 15 min at 95° for Taq activation. Samples were subjected to 35 cycles of melting (30 s at 95°), annealing (20 s at 50°), and extension (30 s at 72°), with final extension for 10 min at 72°. Reactions were carried out in 1 x PCR buffer containing 1.5 mM MgCl 2 , according to the manufacturers instructions. Specific DNA amplicons excised from agarose gels were extracted by the "Wizard Purification System" (Promega). Bidirectional sequencing was performed in the Mayo Molecular Biology Core Facility by the Taq-dideoxy dye terminator cycle method with sequencespecific oligonucleotide primers. Results of this analysis confirmed the product identities.
Radiometric assays
Thawed tissues were homogenized in five volumes of 50 mM sodium phosphate buffer, pH 7.4, with 0.5% Tween 20; supernatants were obtained after centrifugation at 10,000 g for 10 min.
To evaluate cocaine hydrolase activity in plasma and tissue samples, we used the radiometric assay in supernatant fractions and pellets (rinsed 3 times with original volume of buffer) was assayed as described above. A modified version of the immunoadsorption system was also used to search for circulating antibodies against transduced CocE. In this case, Pansorbin aliquots saturated with linker antibodies against rat IgG or IgM were exposed for 1 h at 37°C to 100 µl samples of rat plasma plus 150 µl of 50 mM sodium phosphate, pH 7.4, followed by 3 cycles of buffer washes and centrifugation at 2000 g for 10 min. These preparations, with adsorbed antibody if any, were then tested for their ability to bind CocE during a 1 h exposure to a standard sample of transduced plasma, using enzyme activity of supernatant and pellet fractions as a guide.
Sucrose density gradient fractionation
Molecular forms of hydrolases were separated on 5 ml gradients of sucrose (5-20%) in 50 mM Tris-HCl (pH 7.4), 1 M NaCl, 0.2 mM EDTA. Samples, with catalase as a sedimentation marker, were centrifuged for 16 h at 35,000 rpm (SWi55.1 rotor, Beckman Instruments, Palo Alto, CA). Numbered fractions (200 µl) recovered from the bottoms of the tubes were assayed for cocaine hydrolase activity.
Statistical analysis and pharmacokinetics.
Student's t-test was used for statistical analysis of group differences in enzyme activity.
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RESULTS

Time course and tissue expression
To track CocE transduction we assayed the enzyme in plasma sampled over three weeks from four rats that received 2.2 x 10 9 PFU of Ad5-CMV-CocE vector on day zero (Fig 1) . On gross inspection these animals appeared in good health. Their plasma CocE activity began rising steeply on day 2, reached a peak at days 5 to 7, then declined sharply. Even at 21 days, however, the activity remained five-fold above pre-treatment levels. By contrast, cocaine hydrolase activity was barely detectable in untreated controls and rats treated with "empty vector" lacking the CocE expression cassette, reflecting the low efficiency of endogenous rat BChE in this reaction.
We utilized selective immunoadsorption to confirm that virally driven CocE expression was directly responsible for the cocaine hydrolase activity measured after vector treatment. Adsorption was performed with B-12, a murine monoclonal antibody previously shown to exhibit high affinity for native human BChE but no measurable affinity for rat BChE (Brimijoin and Mintz, 1983) .
Incubation for 1 h with solid phase B-12 removed 99% of the cocaine hydrolase activity in plasma drawn 5 days after administration of Ad5-CMV-CocE. We concluded that this activity represented transduced enzyme that was recognizable to an anti-human BChE antibody despite having been generated in the rat. In support, the kinetic behavior of this enzyme was very close to that of purified recombinant CocE (mean cocaine K m in plasma samples from two rats was 17 µM).
The tissue distribution of CocE was examined in four other rats treated five days earlier with Ad5-CMV-CocE (Fig. 2) . Identical patterns were seen in whole tissue homogenates and in extracts adsorbed to B-12 antibody (not shown). All seven tissues tested in control rats showed trivial levels of baseline cocaine hydrolase activity (< 0.025 mU/g). After viral transduction, however, activity in liver was 45 ± 3 times greater than in rats treated with empty-vector (which were equivalent to This article has not been copyedited and formatted. The final version may differ from this version. untreated rats). Other tissues showed very small increases in the absolute amount of hydrolase activity, although the 2-3 fold changes in diaphragm, heart, and spleen were statistically significant.
Brain and rinsed erythrocytes displayed virtually no activity before or after transduction.
The foregoing data suggested that liver was the primary source of transduced CocE in plasma. This conclusion was supported by RT-PCR analysis of mRNA extracted from a set of tissues sampled five and nine days after vector injection, which yielded CocE cDNA amplicons only in liver and only at the 5-day point (Fig. 3) . In light of this result, the time course of enzyme expression in liver was followed in two rats. The data showed that, after rising steadily to a peak on day 5, cocaine hydrolase activity largely disappeared from liver by day 7 (Fig. 4 ). This finding, consistent with the failure to detect CocE mRNA at 9 days, led us to investigate the stability and half-life of the transduced CocE circulating in plasma.
Stability of transduced CocE
CocE half-life was assessed directly in the following way. Plasma from six transduced rats (5 days after exposure to Ad5-CMV-CocE, 2.2 x 10 9 PFU) was collected and injected into an equal number of naïve recipient rats. Circulating cocaine hydrolase activity in the recipients was observed to decline in a simple exponential manner with a half-life (t 1/2 ) of 33 ± 2.6 h ( Fig. 5 ).
Three experiments with transduced AME 359 indicated a similar pattern of decay with a slightly shorter t 1/2 of 27 ± 1.7 h (not shown). This result contrasted with the behavior of recombinant CocE purified from CHO cells, which decayed in bi-exponential fashion with an initial t 1/2 of 40 min and a terminal t 1/2 of 12 h.
We tested the possibility that the persistence of CocE in passive recipients might have BChE stability is influenced by oligomeric state. Therefore, ultracentrifugation on sucrose density gradients was used to compare the molecular forms of recombinant and virally transduced enzymes ( Fig. 6 ). Recombinant CocE and transduced AME 359 both contained large amounts of the stable tetrameric form but also a substantial fraction of low molecular weight enzyme. Transduced
CocE, in contrast, was entirely tetrameric, like native plasma BChE of humans and rats.
Since CocE was transduced as a highly stable tetramer it was surprising that plasma cocaine hydrolase activity dropped so rapidly after one week. To determine if immune reactions might play a destabilizing role we investigated one rat that had shown a particularly sharp loss after day five, dropping to 0.2% of peak on day nine. That same day, 4 min after this rat received 1 ml of plasma from a day-5 donor, cocaine hydrolase activity rose only to 10% of the expected level. The activity then fell 85% in 1 h, and it became undetectable by 6 h (data not shown). 
Accelerated cocaine metabolism after transduction of hydrolases
Before evaluating effects on cocaine's pharmacokinetics and pharmacodynamics, the doseresponse relations of viral transduction were examined. Raising the dose of Ad5-CMV-CocE by factors of 3, 5, and 10 caused progressively greater transduction of plasma CocE (Fig. 7) . Mean cocaine hydrolase activity 5 days after transduction with the highest dose was 50 ± 8 mU/ml, equivalent to 27 µg/ml of purified protein. That value represents a 3000-fold increase above baseline. Still greater cocaine hydrolase activity, averaging 780 ± 400 mU/ml, or 50,000-fold above baseline, was seen after transduction with an equivalent dose of Ad5-CMV-AME 359 .
To determine whether a transduced hydrolase would accelerate cocaine metabolism we began with an in vitro approach. Cocaine in a final concentration of 37 µM was added to plasma from one control rat and one rat transduced 5 days earlier with Ad5-CMV-CocE (11 x 10 9 PFU).
These samples contained, respectively, 0.05 mU and 100 mU of CocE per ml. Although cocaine was extremely stable in the control plasma, it disappeared from the transduced plasma within an hour, replaced by near stoichiometric amounts of the metabolite, benzoic acid (Fig. 8) .
The metabolic effect of transduced CocE was somewhat weaker in vivo. On average, rats transduced with 11 x 10 9 PFU of vector expressed only half as much CocE as the donor for the in vitro experiment. This level of expression scarcely affected the rate of cocaine elimination after i.v.
injection, though it significantly reduced the amount of drug in the initial sample (Fig. 9) . Cocaine elimination was faster in individual rats with the highest levels of CocE activity, however, and was extremely rapid in animals transduced with the still more efficient hydrolase, AME 359 . Plasma from AME-transduced rats sampled 4 min after drug injection contained 95% less cocaine than comparable samples from control rats. At the same time, these animals showed marked reductions of cocaine in brain (55%) and heart (85%), together with benzoic acid levels that were far above This article has not been copyedited and formatted. The final version may differ from this version. normal. These pharmacokinetic effects warranted a study of physiological responses in rats expressing exogenous hydrolases.
Physiological impact of transduced hydrolases
Rats given high doses of vector (11 x 10 9 PFU) remained normal in general appearance, motor activity, and body weight, although some showed yellow plasma. We examined pressor responses to cocaine 5 days after high-dose transduction. Four groups were studied: untreated (n = 13); empty vector (n = 5); Ad5-CMV-CocE (n = 8); and Ad5-CMV-AME 359 (n = 5). The rats were anesthetized with urethane and instrumented for continuous recording of blood pressure in the femoral artery. After stabilization, all animals were pretreated with atropine in order to prolong their pressor response (see Methods). Ten min later they were challenged with i.v. cocaine, 3.5 mg/kg. Because cocaine caused the same effects in rats given empty vector as in untreated rats (Fig. 10A) , data from these animals were pooled. The combined results demonstrated a statistically significant reduction of pressure in the CocE group and a more substantial effect in the AME 359 group (Fig. 10B) . The reduction in both cases was apparent within 60 s after cocaine injection. At this time, control rats still showed a 20 mm Hg elevation of blood pressure, about 70% of the initial response, while pressure in the CocE and AME groups was only 13 and 5 mm Hg above baseline, respectively. The effect of AME treatment was not only larger, but also progressive; in fact blood pressure reached normal levels within a few min and remained so for the duration of measurement.
Rats treated with the CocE vector, in contrast, failed to completely normalize pressure, which remained near 15 mm Hg for at least 10 min.
This article has not been copyedited and formatted. The final version may differ from this version. These findings support the feasibility of metabolically based gene therapies for cocaine toxicity and abuse. The data also highlight issues that must be resolved before such therapies can be realized.
Tissue distribution is one issue. CocE transduction occurred largely in the liver, consistent with the hepatotropism of type-5 adenoviral vectors (Connelly and Mech, 2004; Shah et al., 2000) .
The liver, specialized for metabolism of xenobiotic compounds, is a favorable site for transduced hydrolases to enhance cocaine clearance. However, expression in targets like brain, heart, and blood vessels is also desirable. Although such tissues acquired measurable hydrolase activity when recombinant CocE was injected (Gao and Brimijoin, 2004), they were less affected by transduction.
In the present study, plasma and liver of rats transduced with Ad5-CMV-CocE displayed peak cocaine hydrolase activities close to those previously seen after injection of CocE. But brain, heart and lung showed 5-fold lower CocE levels after transduction than after enzyme injection, while diaphragm, kidney, and spleen showed 15-fold lower levels.
The different distributions of CocE activity after injections of protein or vector probably reflect differences in enzyme fate. Recombinant CocE not only has a shorter terminal half-life than transduced CocE but also exhibits a "redistribution phase" after i.v. injection. We suspect this rapid initial clearance involves adsorption onto reticuloendothelial cells in lung, liver, spleen, and kidney, and to a lesser extent elsewhere. Adsorption may be greater if the enzyme is not fully glycosylated and assembled into tetramers, or is derived from a foreign species (Kronman et al., 1995; Saxena et This article has not been copyedited and formatted. The final version may differ from this version. A second issue raised by our results is the time-course of hydrolase transduction. Although expression was detectable for three weeks, the drop soon after peak expression was striking. This pattern, often seen with adenoviral vectors, is thought to reflect immunologic reactions including Tcell-mediated attack on vector-containing host cells and humoral inactivation of transduced proteins (Dai et al., 1995; Yang et al., 1995) . Both reactions were likely in rats given Ad5-CMV-CocE or -AME 359 . We did not perform histology to confirm an inflammatory process, but the rats examined five days or more after transduction had bright yellow plasma and swollen livers. These signs point to hepatitis and are consistent with the disappearance of CocE mRNA from liver within nine days. , 2004) . Surprisingly, such factors appear not to have limited the viral transduction of the mutant hydrolase. Although AME 359 was less well assembled into tetramers, the relative abundance of its activity in plasma suggests that this protein may have expressed even more readily than CocE.
The present results support our recent finding that injection of a cocaine hydrolase will reduce cardiovascular responses to cocaine in a highly specific manner, by accelerating metabolic elimination (Gao and Brimijoin, 2004) . The results also show that similar but more lasting effects can be achieved by viral transduction. Such effects could aid in reducing cocaine toxicity or in MOL-6924 for all but life-threatening conditions must wait until genes can be delivered without substantial risk. Furthermore, the prospects for reducing the psychic rewards of cocaine abuse by increased metabolism are uncertain, despite the impressive decrease in cardiovascular responses in rats with high hydrolase activity. One reason is that the brain is a preferred site of cocaine uptake. Thus, the brains of transduced rats with drastically reduced pressor responses, and correspondingly little drug in the heart, still accumulated 45% as much cocaine as did controls. Much of this residual load may be functionally irrelevant, e.g. dissolved in myelin, but some is likely to reach dopamine transporters and other targets. Therefore, to create a still more effective barrier to the CNS effects of cocaine, hydrolase activity may be needed in the brain vasculature or the brain parenchyma itself.
Expression in the nervous system will be essential if tests of self-administration in animals indicate that transduction solely in the periphery intensifies drug-seeking by eliminating side effects while CocE at day zero. Liver samples were collected from 2 rats at each time point after NaCl perfusion.
Mean levels of cocaine hydrolase activity are shown. H-cocaine, 37 µM, was added to plasma from a rat treated 5 days earlier with 11 x 10 9 PFU Ad5-CMV-CocE. Levels of cocaine and the metabolite, benzoic acid (BA), were determined at multiple times by radiometric assay (see Methods). Ad5-CMV-CocE in a dose of 11 x 10 9 PFU ('CocE', n = 9) or 22 x 10 9 PFU ('CocE high', n = 1).
Four other rats received 11 x 10 9 PFU of Ad5-CMV-AME 359 ('AME 359 '). One control rat received the same dose of empty Ad5-CMV vector; two others were untreated. Five days after transduction, a dose of 30 µCi of 3 H-cocaine (3.5 mg/kg) was injected, i.v.; blood samples at the indicated times were assayed for radiolabeled cocaine and benzoic acid. Means ± SEM are shown. The effect of CocE transduction was statistically significant at the 5-min point only (t-test, p < 0.05), but AME 359 transduction dramatically reduced cocaine at all tested times. B) Changes in tissue cocaine and benzoic acid. Three control rats and three Ad5-CMV-AME 359 rats were euthanized 5 min after injection of 3 H-cocaine, and, heart and brain samples were collected after saline perfusion. Means ± SEM are shown in units of µM/kg (assuming for plasma, ρ ≈ 1 kg/l). The reductions in cocaine content and increases in benzoic acid in transduced tissues were all significant by t-test (p <0.005).
This article has not been copyedited and formatted. The final version may differ from this version. Lower panel, comparison of transduced rats with pooled controls (untreated rats and rats given empty vector). Two-way ANOVA showed high significance (p < 0.0001) in the effects of transduction with Ad5-CMV-CocE (during the first 360 s after cocaine) and with Ad5-CMV-AME 359 (throughout the observation window).
This article has not been copyedited and formatted. The final version may differ from this version. 
